Bryxta 400mg Bevacizumab Injection

Bevacizumab 400mg price in India, Uses and Side Effects

BEVACUZUMAB 400MG PRICE

Price: INR 11500/Vial | MRP INR 57566

Packaging Type Vial
Composition Bevacizumab
Strength 100mg/400mg
Brand Bryxta 400
Manufacturer Zydus

FAQ - Bevacizumab

Bevacizumab injection is an anticancer injection. It is used in the treatment of colon and rectal cancer, non-small cell lung cancer, kidney cancer, brain tumours, ovarian and cervical cancer, and other cancer.

 

  • Black, tarry stools.
  • body aches or pain.
  • burning, tingling, numbness, or pain in the hands, arms, feet, or legs.
  • chest pain, discomfort, or tightness.
  • cloudy urine.
  • cracks in the skin.
  • decreased urine output.
  • difficult or labored breathing.

Bevacizumab works by selectively binding circulating VEGF and inhibiting its binding to cell surface receptors. This inhibition reduces the microvascular growth of tumour blood vessels, limiting the blood supply to tumour tissues.

Avastin is approved to treat metastatic colorectal cancer (mCRC) for:

  • First- or second-line treatment in combination with intravenous fluorouracil-based chemotherapy
  • Second-line treatment when used with fluoropyrimidine-based (combined with irinotecan or oxaliplatin) chemotherapy after cancer progresses following a first-line treatment containing bevacizumab

Avastin is not approved for use in patients with colon cancer that has not spread to other parts of the body after surgery was used as the primary treatment. 

 

Bevacizumab-awwb injection is given with other medicines to treat patients with metastatic (cancer that has spread) carcinoma of the colon or rectum.

 

 

Atezolizumab Plus Bevacizumab Approved to Treat Liver Cancer… people with hepatocellular carcinoma (HCC), a type of liver cancer.